Caklili, O. T. Et Al. 2022. Optimal testosterone level to improve symptoms of hypogonadism without causing dopa-testotoxicosis in male macroprolactinoma. ANNALES D ENDOCRINOLOGIE , vol.83, no.1 , 9-15.

Caklili, O. T., Ok, A. M., Istemihan, Z., Selcukbiricik, Ö., & Yarman, S., (2022). Optimal testosterone level to improve symptoms of hypogonadism without causing dopa-testotoxicosis in male macroprolactinoma. ANNALES D ENDOCRINOLOGIE , vol.83, no.1, 9-15.

Caklili, Özge Et Al. "Optimal testosterone level to improve symptoms of hypogonadism without causing dopa-testotoxicosis in male macroprolactinoma," ANNALES D ENDOCRINOLOGIE , vol.83, no.1, 9-15, 2022

Caklili, Özge T. Et Al. "Optimal testosterone level to improve symptoms of hypogonadism without causing dopa-testotoxicosis in male macroprolactinoma." ANNALES D ENDOCRINOLOGIE , vol.83, no.1, pp.9-15, 2022

Caklili, O. T. Et Al. (2022) . "Optimal testosterone level to improve symptoms of hypogonadism without causing dopa-testotoxicosis in male macroprolactinoma." ANNALES D ENDOCRINOLOGIE , vol.83, no.1, pp.9-15.

@article{article, author={Özge TELCİ ÇAKLILI Et Al. }, title={Optimal testosterone level to improve symptoms of hypogonadism without causing dopa-testotoxicosis in male macroprolactinoma}, journal={ANNALES D ENDOCRINOLOGIE}, year=2022, pages={9-15} }